Original Research
Published on 12 Jun 2025
Heart failure medication treatment and prognosis: a retrospective cross-sectional study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532123
- 111 views
Type at least 3 characters
472 articles
Original Research
Published on 11 Jun 2025
Influence of the estimated glomerular filtration rate equation on carboplatin dosing: a real-world study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1605458
- 162 views
Original Research
Published on 10 Jun 2025
Exploring multidimensional determinants of medication error reporting in China: a qualitative study using the theoretical domains framework
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1590794
- 417 views
Original Research
Accepted on 09 Jun 2025
Comparative Analysis of Thrombocytopenia Incidence in Patients Treated with Generic vs. Brand-Name Linezolid: A Cohort Study Utilizing Hospital Electronic Medical Records
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1528633
Original Research
Published on 09 Jun 2025
Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516449
- 553 views
Original Research
Accepted on 05 Jun 2025
Adverse drug reaction signal detection via the Long Short-Term Memory model
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1554650
- 125 views
Original Research
Accepted on 05 Jun 2025
Pharmacovigilance-related events, disease burden and overall efficiency of care in European countries, 1990-2021
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592957
Original Research
Accepted on 04 Jun 2025
Antihypertensive medications and cancer risk: evidence from 0.27 million patients with newly diagnosed hypertension
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559604
- 138 views
Original Research
Accepted on 03 Jun 2025
Application and Evaluation of the Global Trigger Tool Approach to Adverse Drug Event Monitoring in the high-risk elderly inpatients with multiple chronic diseases
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594176
Original Research
Accepted on 02 Jun 2025
What Drives Hyperammonemic Encephalopathy in AED Users: Monotherapy Risks or Polypharmacy Perils?
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1477127
- 144 views
Original Research
Published on 30 May 2025
Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1553221
- 379 views
Original Research
Published on 30 May 2025
Emerging cardiovascular toxicity associated with CDK4/6 inhibitors: real-world insights from the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558128
- 529 views
Original Research
Published on 26 May 2025
Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1518258
- 690 views
Original Research
Accepted on 22 May 2025
Chloroquine and Hydroxychloroquine-Related Ocular Adverse Events in SLE Treatment: A Real-World Disproportionality Analysis Based on FDA Adverse Event Reporting System (FAERS) Author
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1498814
- 198 views
Original Research
Published on 22 May 2025
Prevalence and factors associated with Chinese herbal medicine use among middle-aged and older Chinese adults with diabetes mellitus
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1482228
- 771 views
Systematic Review
Published on 22 May 2025
A systematic review with meta-analysis on the efficacy of 0.01% atropine eyedrops in preventing myopia progression in worldwide children’s populations
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1497667
- 917 views